Do We Get Samples of the Report?

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

How to Buy a Market Report?

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

In Which Format Will I Get the Report?

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

In How Much Time I will Get the Report After Purchase?

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

How Can I Get the Report Customized?

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

How Much Will It Cost to Get a Report Customized?

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

Can I Buy Only a Particular Segment of the Study?

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Is There Any Available Discount?

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

Which Services Are Complimentary Before Purchasing the Report?

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Will I Receive a Bill or Invoice for the Report Purchased?

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

What If I am Unable to Find the Report in the Catalog?

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

How Often Are the Existing Studies Updated?

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

What If the Report Does Not Contain the Information I Want?

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Is the Payment Refundable?

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

What If the Payment Fails?

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Can I Avail the Report of a Particular Country/Region?

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Do You Offer Support After Purchase?

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.

Transition Therapeutics Inc (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DESCRIPTION

TABLE OF CONTENTS

RELATED REPORTS

SAMPLE REQUEST

REVIEWS

DESCRIPTION

Summary

Transition Therapeutics Inc (Transition) is a biopharmaceutical company that develops medicines for the treatment of CNS disorders, Alzheimers disease and diabetes. The company is developing drugs for the treatment of aggression associated with Down syndrome and Alzheimers disease. It is also developing a metabolic drug candidate for the treatment of type two diabetes and accompanying obesity. Transition is also currently conducting clinical trials on several upcoming drugs for the treatment of various diseases. It partners with various other biopharmaceutical companies to market its products. Transition is headquartered in Toronto, Ontario, Canada.

Transition Therapeutics Inc (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

TABLE OF CONTENTS

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Transition Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Transition Therapeutics Enters into Agreement with Brigham and Womens Hospital 10
Perrigo Amends Development And Commercialization Agreement With Transition Therapeutics For ELND005 11
Licensing Agreements 12
Transition Therapeutics Enters into Licensing Agreement with Eli Lilly for TT701 12
Transition Therapeutics Enters Into Licensing Agreement With Eli Lilly For TT-601 13
Transition Therapeutics and Eli Lilly Amend Licensing Agreement 14
Equity Offering 16
Transition Therapeutics Raises USD23 Million in Public Offering of Shares 16
Transition Therapeutics Raises USD17 Million in Private Placement of Units 17
Transition Therapeutics Completes Private Placement Of Shares For US$11 Million 19
Transition Therapeutics Completes Non-Brokered Private Placement Of Shares For US$5 Million 20
Acquisition 21
OPKO Health Acquires Transition Therapeutics for USD60 Million 21
Perrigo To Acquire 7% Stake In Transition Therapeutics For US$15 Million 22
Transition Therapeutics Inc - Key Competitors 23
Transition Therapeutics Inc - Key Employees 24
Transition Therapeutics Inc - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
May 11, 2016: Transition Therapeutics Announces Third Quarter Fiscal 2016 Financial Results 26
Feb 09, 2016: Transition Therapeutics Announces Second Quarter Fiscal 2016 Financial Results 28
Corporate Communications 30
Jun 03, 2016: Transition Therapeutics Receives Notification From NASDAQ 30
Mar 17, 2016: Transition Therapeutics Receives Notification From NASDAQ 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List Of Tables

List of Tables
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Transition Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Transition Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Transition Therapeutics Enters into Agreement with Brigham and Womens Hospital 10
Perrigo Amends Development And Commercialization Agreement With Transition Therapeutics For ELND005 11
Transition Therapeutics Enters into Licensing Agreement with Eli Lilly for TT701 12
Transition Therapeutics Enters Into Licensing Agreement With Eli Lilly For TT-601 13
Transition Therapeutics and Eli Lilly Amend Licensing Agreement 14
Transition Therapeutics Raises USD23 Million in Public Offering of Shares 16
Transition Therapeutics Raises USD17 Million in Private Placement of Units 17
Transition Therapeutics Completes Private Placement Of Shares For US$11 Million 19
Transition Therapeutics Completes Non-Brokered Private Placement Of Shares For US$5 Million 20
OPKO Health Acquires Transition Therapeutics for USD60 Million 21
Perrigo To Acquire 7% Stake In Transition Therapeutics For US$15 Million 22
Transition Therapeutics Inc, Key Competitors 23
Transition Therapeutics Inc, Key Employees 24
Transition Therapeutics Inc, Subsidiaries 25

List Of Figures

List of Figures
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Transition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

RELATED REPORTS

Transitional Endoplasmic Reticulum ATPase (Valosin Containing Protein or 15S Mg(2+) ATPase p97 Subunit or VCP or EC 3.6.4.6) - Drugs in Development, 2021

Transitional Endoplasmic Reticulum ATPase (Valosin Containing Protein or 15S Mg(2+) ATPase p97 Subunit or VCP or EC 3.6.4.6) - Drugs in Development, 2021Transitional Endoplasmic Reticulum ATPase (Valosin Containing Protein or

USD 3000 View Report

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) (Oncology) - Drugs in Development, 2021

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) (Oncology) - Drugs in Development, 2021Transitional Cell Carcinoma (Urothelial Cell Carcinoma) (Oncology) - Drugs in Development, 2021 provides an overview of the Transitional Cell

USD 2000 View Report

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2021 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for degenerative orthopedic diseases and traumatic conditions. It offers solutions for ortho-biologics, dermal, ophthalmic, surgical and veterinary applications. Its major

USD 750 View Report

Chinook Therapeutics Inc (KDNY) - Financial and Strategic SWOT Analysis Review

Chinook Therapeutics, Inc (Chinook)., formerly Aduro BioTech Inc is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using

USD 300 View Report

SAMPLE REQUEST

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

REVIEWS

There is no Reviews available

Search and Get the Latest Market Research Reports

Transition Therapeutics Inc (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Transitional Endoplasmic Reticulum ATPase (Valosin Containing Protein or 15S Mg(2+) ATPase p97 Subunit or VCP or EC 3.6.4.6) - Drugs in Development, 2021

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) (Oncology) - Drugs in Development, 2021

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2021 Update

Chinook Therapeutics Inc (KDNY) - Financial and Strategic SWOT Analysis Review

FAQs